ADCT EPS Estimates
ADC Therapeutics S.A.
$1.45
-$0.25(-14.71%)
55
Overall
40
Value
75
Tech
52
Quality
Market Cap
$185.12M
Volume
1.74M
52W Range
$0.78 - $4.98
Target Price
$3.33
ADCT EPS estimates: the consensus estimate for ADC Therapeutics S.A.'s current fiscal year is -$0.80 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ADCT EPS Estimates
- EPS estimate, current quarter
- $-0.21
- EPS estimate, next quarter
- $-0.23
- EPS estimate, current year
- $-0.80
- EPS estimate, next year
- $-0.76
- EPS growth, 3-year
- +17.44%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.12 |
| 2024 | $-1.62 |
| 2023 | $-2.94 |
| 2022 | $-1.99 |
| 2021 | $-3.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADCT | $1.45 | -14.7% | 1.74M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |